Literature DB >> 19443078

Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.

L F A Camargo1, A R Marra, G L Büchele, A M C Sogayar, R G R Cal, J M A de Sousa, E Silva, E Knobel, M B Edmond.   

Abstract

Antimicrobial- and antiseptic-impregnated catheters are strategies recommended to prevent central venous catheter (CVC) colonisation. Few data regarding chlorhexidine/silver sulfadiazine-impregnated catheters in intensive care unit (ICU) patients have been reported. We performed a prospective, randomised study comparing the colonisation rates of chlorhexidine/silver sulfadiazine-impregnated CVCs (group 1) against standard CVCs (group 2). In order to assess catheter colonisation rates, a 4cm segment from the tips of aseptically removed catheters was cultured by the roll-plate method. In all, 109 patients were enrolled with successful catheter insertion, 51 of them in group 1 and 58 in group 2. There were no statistically significant differences between the two groups with regards to age, Sequential Organ Failure Assessment (SOFA) score, ICU admission diagnosis, infection risk, catheter insertion sites or catheter length of stay. The colonisation rates were 29.4% (15 catheters) for group 1 and 34.5% (20 catheters) for group 2 (P=0.50). Double-lumen CVCs impregnated with chlorhexidine and silver sulfadiazine were not effective in reducing the incidence of catheter colonisation in ICU patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443078     DOI: 10.1016/j.jhin.2009.03.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

Review 1.  Use of silver in the prevention and treatment of infections: silver review.

Authors:  Amani D Politano; Kristin T Campbell; Laura H Rosenberger; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-02-28       Impact factor: 2.150

2.  Characterization of post-hospital infections in adults requiring home parenteral nutrition.

Authors:  Vivian M Zhao; Daniel P Griffith; Henry M Blumberg; Nisha J Dave; Cynthia H Battey; Therese A McNally; Kirk A Easley; John R Galloway; Thomas R Ziegler
Journal:  Nutrition       Date:  2012-08-02       Impact factor: 4.008

3.  Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study.

Authors:  Hyun Jung Kim; Jina Yun; Han Jo Kim; Kyoung Ha Kim; Se Hyung Kim; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Kyu Taek Lee; Seong Kyu Park; Jong-Ho Won; Hee Sook Park; Dae Sik Hong
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

Review 4.  Randomized controlled trials in central vascular access devices: A scoping review.

Authors:  Mari Takashima; Gillian Ray-Barruel; Amanda Ullman; Samantha Keogh; Claire M Rickard
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

Review 5.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16

Review 6.  Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis.

Authors:  Hongliang Wang; Hongshuang Tong; Haitao Liu; Yao Wang; Ruitao Wang; Hong Gao; Pulin Yu; Yanji Lv; Shuangshuang Chen; Guiyue Wang; Miao Liu; Yuhang Li; Kaijiang Yu; Changsong Wang
Journal:  Ann Intensive Care       Date:  2018-06-15       Impact factor: 6.925

Review 7.  Second-Generation central venous catheter in the prevention of bloodstream infection: a systematic review.

Authors:  Janislei Gislei Dorociaki Stocco; Hellen Hoers; Franciele Soares Pott; Karla Crozeta; Dulce Aparecida Barbosa; Marineli Joaquim Meier
Journal:  Rev Lat Am Enfermagem       Date:  2016-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.